These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9413466)

  • 1. Effect of danaparoid sodium on hard exudates in diabetic retinopathy.
    van der Pijl JW; van der Woude FJ; Swart W; van Es LA; Lemkes HH
    Lancet; 1997 Dec; 350(9093):1743-5. PubMed ID: 9413466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of danaparoid sodium on proteinuria, von Willebrand factor, and hard exudates in patients with diabetes mellitus type 2.
    van der Pijl JW; Lemkes HH; Frölich M; van der Woude FJ; van der Meer FJ; Van Es LA
    J Am Soc Nephrol; 1999 Jun; 10(6):1331-6. PubMed ID: 10361873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Danaparoid sodium lowers proteinuria in diabetic nephropathy.
    van der Pijl JW; van der Woude FJ; Geelhoed-Duijvestijn PH; Frölich M; van der Meer FJ; Lemkes HH; van Es LA
    J Am Soc Nephrol; 1997 Mar; 8(3):456-62. PubMed ID: 9071714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Danaparoid sodium in diabetic retinopathy.
    Gambaro G
    Lancet; 1998 Feb; 351(9103):674. PubMed ID: 9500356
    [No Abstract]   [Full Text] [Related]  

  • 5. [Danaparoid sodium for dialysis in heparin-associated thrombocytopenia].
    Ben Ami R; Rachmimov R; Berliner S
    Harefuah; 1999 Mar; 136(5):361-4, 419. PubMed ID: 10914239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Danaparoid sodium].
    Kitazawa Y
    Rinsho Byori; 2011 Feb; Suppl 147():164-6. PubMed ID: 21761765
    [No Abstract]   [Full Text] [Related]  

  • 7. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators.
    JAMA; 1998 Apr 22-29; 279(16):1265-72. PubMed ID: 9565006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical experience with Danaparoid-sodium: measures to be taken in heparin-induced thrombocytopenia].
    Chirurg; 1998 Nov; 69(11 Suppl Massnahme):1-4. PubMed ID: 9853175
    [No Abstract]   [Full Text] [Related]  

  • 9. Fatal danaparoid-sodium induced thrombocytopenia and arterial thromboses.
    Tardy B; Tardy-Poncet B; Viallon A; Piot M; Mazet E
    Thromb Haemost; 1998 Sep; 80(3):530. PubMed ID: 9759647
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapid reduction of hard exudates in eyes with diabetic retinopathy after intravitreal triamcinolone: data from a randomized, placebo-controlled, clinical trial.
    Larsson J; Kifley A; Zhu M; Wang JJ; Mitchell P; Sutter FK; Gillies MC
    Acta Ophthalmol; 2009 May; 87(3):275-80. PubMed ID: 18785964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical experiences with Danaparoid sodium. Measures to be taken in heparin-induced thrombocytopenia].
    Anaesthesist; 1998 Nov; 47(11 Suppl Massnahmen):1-4. PubMed ID: 9884734
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment by danaparoid sodium for portal venous thrombosis].
    Shudo R; Yazaki Y; Sugawara K; Honda M
    Nihon Shokakibyo Gakkai Zasshi; 2007 Feb; 104(2):205-12. PubMed ID: 17283415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ardeparin and danaparoid for prevention of deep vein thrombosis.
    Med Lett Drugs Ther; 1997 Oct; 39(1011):94-5. PubMed ID: 9379998
    [No Abstract]   [Full Text] [Related]  

  • 14. Heparin-induced thrombocytopenia type II: perioperative management using danaparoid in a coronary artery bypass patient with renal failure.
    Westphal K; Martens S; Strouhal U; Matheis G; Lindhoff-Last E; Wimmer-Greinecker G; Lischke V
    Thorac Cardiovasc Surg; 1997 Dec; 45(6):318-20. PubMed ID: 9477469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Danaparoid Sodium and Synthetic Protease Inhibitors for the Treatment of Disseminated Intravascular Coagulation Associated with Hematological Malignancies: A Retrospective Analysis.
    Minakata D; Fujiwara SI; Hayakawa J; Nakasone H; Ikeda T; Kawaguchi SI; Toda Y; Ito S; Ochi SI; Nagayama T; Mashima K; Umino K; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Sugimoto M; Ishihara Y; Yamamoto C; Ashizawa M; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Ohmori T; Kanda Y
    Acta Haematol; 2020; 143(3):250-259. PubMed ID: 31461700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical coherence tomographic evaluation of foveal hard exudates in patients with diabetic maculopathy accompanying macular detachment.
    Ota M; Nishijima K; Sakamoto A; Murakami T; Takayama K; Horii T; Yoshimura N
    Ophthalmology; 2010 Oct; 117(10):1996-2002. PubMed ID: 20723993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Danaparoid is not a low-molecular-weight heparin.
    Nicholson CD; Meuleman DG; Magnani HN; Egberts JF; Leibowitz DA; Spinler SA; Cziraky MJ
    Am J Hosp Pharm; 1994 Aug; 51(16):2049-50. PubMed ID: 7526686
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of heparin allergy during pregnancy with danaparoid.
    Harrison SJ; Rafferty I; McColl MD
    Blood Coagul Fibrinolysis; 2001 Mar; 12(2):157-9. PubMed ID: 11302479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of dyslipidaemia with macular oedema and hard exudates in diabetic maculopathy.
    Golubovic-Arsovska M
    Prilozi; 2007 Dec; 28(2):149-60. PubMed ID: 18356786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of systemic risk factors with the severity of retinal hard exudates in a north Indian population with type 2 diabetes.
    Sachdev N; Sahni A
    J Postgrad Med; 2010; 56(1):3-6. PubMed ID: 20393241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.